The Inspiration

11 07, 2020

COVID-19 Office Safety


Our priority is the safety of our staff and patients. In response to the 2019 novel coronavirus (COVID-19) changes are in place at IRL. We are open by appointment only, for those who are coming in the following measures are in place at our building and office to ensure patient safety. All visitors, patients, staff [...]

COVID-19 Office Safety2020-07-11T21:11:41+00:00
31 03, 2020

Knowledge is Power: Inhaler Adherence Rates in Asthma


This study by GlaxoSmithKline (GSK) looked to see how the Connected Inhaler System affected adherence to Relvar/Breo Ellipta treatment in patients with poorly controlled asthma. Narrowing of chest coughing, wheezing, chest tightness and shortness of breath. We may have experienced some of these unpleasant symptoms at some point but for those suffering from Asthma, these [...]

Knowledge is Power: Inhaler Adherence Rates in Asthma2020-03-31T21:51:51+00:00
23 03, 2020

COVID-19 Care updates


Coranavirus 19 – Suggestions for patients asthma, COPD and other chronic respiratory illnesses During these early days of the Covid 19 crisis, I’ve spent much of my time on the telephone with my patients.  I’m not seeing patients routinely in my office and for the most part, it’s been a matter of verifying that my [...]

COVID-19 Care updates2020-03-23T20:39:03+00:00
15 03, 2020

Chronic Coughs


             Everyone coughs, but some people cough almost constantly. Coughs can disrupt sleep, exhaust the coughing patient and can get in the way of simply enjoying life. If the cough is temporary and due to an infection, one can simply wait for the cough to go away.  Sometimes the cough [...]

Chronic Coughs2020-03-15T21:22:35+00:00
4 03, 2020

Shinead M Callery


With the diverse roles at Inspiration Research, it takes a diverse team. On the front end interacting with participants takes great awareness and sensitivity to educate them on the sensitivities of research. This needs to be balanced with the strict demands of research. Striking this balance is challenging but Inspiration research Shinead was more than [...]

Shinead M Callery2020-03-04T21:25:54+00:00
17 02, 2020

Jane Duke


It takes a dedicated team to allow Inspiration Research Limited (IRL) to hold its place as a respected and renowned research team in the field of respiratory health. With more than 800 registered clients and 7 specialized team members. Today we will learn more about one key team member: Senior Clinical Trial Manager, Jane Duke.  [...]

Jane Duke2020-02-12T00:35:47+00:00
20 12, 2019

November and December 2019 Review


As Alpha- One awareness month, November brought lots of excitement. The 13th Annual Day in Respirology with UofT got the ball rolling on the 8th. This year’s up featured notable speakers in the field. The day was filled with insights on the developments in the field and how to address major challenges as we [...]

November and December 2019 Review2020-02-12T00:41:35+00:00
17 03, 2016

DECAF score predicts acute COPD exacerbation mortality


DECAF score predicts acute COPD exacerbation mortality Preventing COPD exacerbations has become an important goal in clinical management and a primary outcome in many COPD research trials. This is understandable - not only is the worsening of COPD distressing for patients but exacerbations can be severe enough to result in hospitalization and death. [...]

DECAF score predicts acute COPD exacerbation mortality2019-06-18T23:43:42+00:00
16 03, 2016

COPD Symposium Online!


COPD Symposium Online! I’ve been slow to catch up to this development even though I’ve been a part of it. Each year, the European Respiratory Society holds its annual scientific meeting to share late-breaking news in the field of respiratory medicine. It’s a sprawling meeting hosting more than 20,000 international attendees who may [...]

COPD Symposium Online!2020-02-12T00:45:38+00:00
14 05, 2014

Inspiration Research Contributes to Groundbreaking Study


Inspiration Research Contributes to Groundbreaking Study KAMADA Pharmaceutical ("Kamada") conducted a Phase II/III clinical trial on the efficacy of proprietary inhaled Alpha-­1 Antitrypsin (AAT) therapy for the treatment of Alpha-­1 Antitrypsin Deficiency (AATD or inherited emphysema) which involved a multi-centre, randomized, double-blind, placebo-controlled study designed to evaluate Kamada's formulation of human AAT to [...]

Inspiration Research Contributes to Groundbreaking Study2019-06-18T23:57:42+00:00